As of 2025-10-28, the Relative Valuation of Atara Biotherapeutics Inc (ATRA) is 19.73 USD. This relative valuation is based on P/E multiples. With the latest stock price at 15.59 USD, the upside of Atara Biotherapeutics Inc based on Relative Valuation is 26.6%.
The range of the Relative Valuation is 17.98 - 22.37 USD.
| Range | Selected | |
| Trailing P/E multiples | 21.8x - 23.9x | 23.7x |
| Forward P/E multiples | 22.0x - 27.1x | 24.1x |
| Fair Price | 17.98 - 22.37 | 19.73 |
| Upside | 15.3% - 43.5% | 26.6% |
| Date | P/E |
| 2025-10-17 | 17.94 |
| 2025-10-16 | 18.47 |
| 2025-10-15 | 18.51 |
| 2025-10-14 | 17.70 |
| 2025-10-13 | 18.22 |
| 2025-10-10 | 17.35 |
| 2025-10-09 | 19.48 |
| 2025-10-08 | 19.20 |
| 2025-10-07 | 18.93 |
| 2025-10-06 | 16.94 |
| 2025-10-03 | 17.46 |
| 2025-10-02 | 17.54 |
| 2025-10-01 | 17.50 |
| 2025-09-30 | 17.36 |
| 2025-09-29 | 16.73 |
| 2025-09-26 | 16.64 |
| 2025-09-25 | 16.75 |
| 2025-09-24 | 17.27 |
| 2025-09-23 | 15.71 |
| 2025-09-22 | 14.90 |
| 2025-09-19 | 14.60 |
| 2025-09-18 | 14.62 |
| 2025-09-17 | 14.04 |
| 2025-09-16 | 13.94 |
| 2025-09-15 | 14.46 |
| 2025-09-12 | 14.68 |
| 2025-09-11 | 14.73 |
| 2025-09-10 | 14.27 |
| 2025-09-09 | 14.47 |
| 2025-09-08 | 14.75 |
| 2025-09-05 | 15.64 |
| 2025-09-04 | 15.51 |
| 2025-09-03 | 15.30 |
| 2025-09-02 | 14.95 |
| 2025-08-29 | 14.60 |
| 2025-08-28 | 14.97 |
| 2025-08-27 | 14.96 |
| 2025-08-26 | 15.31 |
| 2025-08-25 | 14.83 |
| 2025-08-22 | 14.95 |
| 2025-08-21 | 13.92 |
| 2025-08-20 | 14.25 |
| 2025-08-19 | 13.91 |
| 2025-08-18 | 13.91 |
| 2025-08-15 | 14.89 |
| 2025-08-14 | 14.20 |
| 2025-08-13 | 14.69 |
| 2025-08-12 | 13.98 |
| 2025-08-11 | 12.50 |
| 2025-08-08 | 13.27 |